Trials / Completed
CompletedNCT00386815
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Safety Confirmation Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To investigate safety of pemetrexed combined with cisplatin for chemo therapy-naive patients with malignant pleural mesothelioma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pemetrexed | |
| DRUG | cisplatin |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-02-01
- First posted
- 2006-10-12
- Last updated
- 2007-04-11
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00386815. Inclusion in this directory is not an endorsement.